Bioelectronics Corp (BIEL)

[rodman]

Focus on 2020 FDA approval! Bielcorp's VP/Board member Keith Nalepka has launched a global roll out of Actipatch products! Here's a review of the electoceutical market in 2019.......

The use of electroceuticals, rather than pharmaceuticals, to treat patients is a rising trend as seen already with the uptake of spinal cord stimulators for the treatment of chronic pain. Electroceuticals provide a more local, targeted and immediate treatment than that provided by traditional pharmaceuticals. Commercial uptake of disruptive technologies such as those listed in this article will be key to driving the future of bioelectronic medicine.

https://www.idtechex.com/en/research-article/six-firsts-in-electroceutical-approvals-of-2019/17604

STILLABELIEVER